Elevation of CSF adenosine deaminase in HIV patient with meningitis from retroviral rebound syndrome, a case report.
Adenosine deaminase
Cerebrospinal fluid
Human immunodeficiency virus
Meningitis
Retroviral rebound syndrome
Journal
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
received:
24
02
2020
revised:
10
06
2020
accepted:
13
06
2020
pubmed:
21
6
2020
medline:
11
11
2020
entrez:
21
6
2020
Statut:
ppublish
Résumé
Adenosine deaminase (ADA) in cerebrospinal fluid (CSF) is considered to be a useful biomarker in differentiating tuberculous meningitis (TBM) from other meningitis in non-HIV patients. However, its specificity decreases in patients with HIV, and other diseases such as cytomegalovirus encephalitis, toxoplasmosis or meningeal lymphomatosis can also elevate ADA in CSF. We here report a rare case of retroviral rebound syndrome in a HIV patient, whose ADA in CSF was elevated.
Identifiants
pubmed: 32562847
pii: S1201-9712(20)30485-9
doi: 10.1016/j.ijid.2020.06.050
pii:
doi:
Substances chimiques
Biomarkers
0
Adenosine Deaminase
EC 3.5.4.4
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
297-298Informations de copyright
Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.